Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline A Austin

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Cell Cycle (Georgetown, Tex.)|August 17, 2012
Do transcription factories and TOP2B provide a recipe for chromosome translocations in therapy-related leukemia?Ian G Cowell, Caroline A Austin
Open Biology|January 11, 2023
DNA fragility at the <i>KMT2A</i>/<i>MLL</i> locus: insights from old and new technologiesIan G Cowell, Caroline A Austin
Plos One|March 2, 2011
The impact of the C-terminal domain on the interaction of human DNA topoisomerase II α and β with DNAKathryn L Gilroy, Caroline A Austin
Methods in Molecular Biology (Clifton, N.J.)|November 28, 2017
Visualization and Quantification of Topoisomerase-DNA Covalent Complexes Using the Trapped in Agarose Immunostaining (TARDIS) AssayIan G Cowell, Caroline A Austin
Analytical Biochemistry|December 7, 2013
A high-throughput fluorescence anisotropy-based assay for human topoisomerase II β-catalyzed ATP-dependent supercoiled DNA relaxationAdam B Shapiro, Caroline A Austin
FEBS Open Bio|March 26, 2024
Myeloperoxidase inhibition protects bone marrow mononuclear cells from DNA damage induced by the TOP2 poison anti-cancer drug etoposideIan G Cowell, Caroline A Austin
International Journal of Environmental Research and Public Health|July 26, 2012
Mechanism of generation of therapy related leukemia in response to anti-topoisomerase II agentsIan G Cowell, Caroline A Austin
Molecular Pharmacology|August 24, 2004
Mutation E522K in human DNA topoisomerase IIbeta confers resistance to methyl N-(4'-(9-acridinylamino)-phenyl)carbamate hydrochloride and methyl N-(4'-(9-acridinylamino)-3-methoxy-phenyl) methane sulfonamide but hypersensitivity to etoposideChrysoula Leontiou, Jeremy H Lakey, Caroline A Austin
Mutation Research|December 23, 2009
The dietary flavonoids myricetin and fisetin act as dual inhibitors of DNA topoisomerases I and II in cellsMiguel López-Lázaro, Elaine Willmore, Caroline A Austin
Journal of Natural Products|April 7, 2007
Cells lacking DNA topoisomerase II beta are resistant to genisteinMiguel López-Lazaro, Elaine Willmore, Caroline A Austin
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Cell Cycle (Georgetown, Tex.)|August 17, 2012
Do transcription factories and TOP2B provide a recipe for chromosome translocations in therapy-related leukemia?Ian G Cowell, Caroline A Austin
Open Biology|January 11, 2023
DNA fragility at the <i>KMT2A</i>/<i>MLL</i> locus: insights from old and new technologiesIan G Cowell, Caroline A Austin
Plos One|March 2, 2011
The impact of the C-terminal domain on the interaction of human DNA topoisomerase II α and β with DNAKathryn L Gilroy, Caroline A Austin
Methods in Molecular Biology (Clifton, N.J.)|November 28, 2017
Visualization and Quantification of Topoisomerase-DNA Covalent Complexes Using the Trapped in Agarose Immunostaining (TARDIS) AssayIan G Cowell, Caroline A Austin
Analytical Biochemistry|December 7, 2013
A high-throughput fluorescence anisotropy-based assay for human topoisomerase II β-catalyzed ATP-dependent supercoiled DNA relaxationAdam B Shapiro, Caroline A Austin
FEBS Open Bio|March 26, 2024
Myeloperoxidase inhibition protects bone marrow mononuclear cells from DNA damage induced by the TOP2 poison anti-cancer drug etoposideIan G Cowell, Caroline A Austin
International Journal of Environmental Research and Public Health|July 26, 2012
Mechanism of generation of therapy related leukemia in response to anti-topoisomerase II agentsIan G Cowell, Caroline A Austin
Molecular Pharmacology|August 24, 2004
Mutation E522K in human DNA topoisomerase IIbeta confers resistance to methyl N-(4'-(9-acridinylamino)-phenyl)carbamate hydrochloride and methyl N-(4'-(9-acridinylamino)-3-methoxy-phenyl) methane sulfonamide but hypersensitivity to etoposideChrysoula Leontiou, Jeremy H Lakey, Caroline A Austin
Mutation Research|December 23, 2009
The dietary flavonoids myricetin and fisetin act as dual inhibitors of DNA topoisomerases I and II in cellsMiguel López-Lázaro, Elaine Willmore, Caroline A Austin
Journal of Natural Products|April 7, 2007
Cells lacking DNA topoisomerase II beta are resistant to genisteinMiguel López-Lazaro, Elaine Willmore, Caroline A Austin
Pageof 8